Decrease in new cases, cure rate now 95.3%

South Africa has identified 4,344 new cases of Covid-19 in the past 24 hours, the National Institute for Communicable Diseases (NICD) confirmed.

This brings the total number of laboratory confirmed cases to 3,891,793.

The country has also reported two new deaths in the past 24 to 48 hours. The cumulative deaths from Covid-19 are 100,755 to date.

According to the NICD, the cumulative number of recoveries now stands at 3,710,696, with a recovery rate of 95.3%.

This is a sharp drop from the 8,015 cases reported on Saturday 14 May.

Covid-19: global developments

‘Deaths from fever’ in North Korea

North Korea reported another 15 deaths from “fever” on Sunday, just days after officially confirming its first cases of Covid-19 and ordering a nationwide blockade.

The epidemic, which according to leader Kim Jong Un is causing “great upheaval”, leaves a country with one of the worst health systems in the world on the brink of potential disaster.

North Korea has no Covid-19 vaccines, antiviral drugs, or mass testing capabilities.

Spain, Morocco to reopen land borders

Rabat and Madrid have agreed to reopen Morocco’s land borders with two Spanish enclaves, the Spanish foreign minister said Wednesday.

The two countries have “reached a definitive agreement for the reopening of land borders with Ceuta and Melilla in the coming days,” Spanish Foreign Minister Jose Manuel Albares told reporters in the Moroccan city of Marrakech, without setting a specific date.

The move helps draw a line under a major diplomatic stalemate in the wake of coronavirus restrictions that together closed the crossings for two years.

Benefits of the J&J vaccine

Meanwhile, the South African Health Products Regulatory Authority (Sahpra) says the benefits of the J&J vaccine in preventing Covid-19 far outweigh the risks.

Two patients who presented with thrombosis or thrombocytopenia syndrome (TTS) after receiving the J&J Covid-19 vaccine made a full recovery.

Of the more than 8.5 million people who received the vaccine in South Africa, only four cases of TTS have been reported. Spra said:

“The risk of TTS is addressed in the Approved Professional Information (PI) and Patient Information Sheet (PIL), SAHPRA said in a statement.

NOW READ: The benefits of the J&J vaccine in preventing Covid-19 far outweigh the risks

Compiled by Cheryl Kahla. Additional reporting by Narissa Subramoney